These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619 [TBL] [Abstract][Full Text] [Related]
8. Liver sympathetic denervation reverses obesity-induced hepatic steatosis. Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754 [TBL] [Abstract][Full Text] [Related]
9. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis. Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF Nutrition; 2022; 103-104():111836. PubMed ID: 36202025 [TBL] [Abstract][Full Text] [Related]
10. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome. Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677 [TBL] [Abstract][Full Text] [Related]
11. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. Malik AN; Simões ICM; Rosa HS; Khan S; Karkucinska-Wieckowska A; Wieckowski MR Cells; 2019 Oct; 8(10):. PubMed ID: 31597406 [TBL] [Abstract][Full Text] [Related]
12. Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet. Baiges-Gaya G; Fernández-Arroyo S; Luciano-Mateo F; Cabré N; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; Romeu M; Nogués MR; Camps J; Joven J J Nutr Biochem; 2021 Mar; 89():108559. PubMed ID: 33264665 [TBL] [Abstract][Full Text] [Related]
13. Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression. Iannone V; Lok J; Babu AF; Gómez-Gallego C; Willman RM; Koistinen VM; Klåvus A; Kettunen MI; Kårlund A; Schwab U; Hanhineva K; Kolehmainen M; El-Nezami H J Nutr Biochem; 2023 May; 115():109307. PubMed ID: 36868506 [TBL] [Abstract][Full Text] [Related]
14. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. Laitakari A; Tapio J; Mäkelä KA; Herzig KH; Dengler F; Gylling H; Walkinshaw G; Myllyharju J; Dimova EY; Serpi R; Koivunen P J Mol Med (Berl); 2020 May; 98(5):719-731. PubMed ID: 32296880 [TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporter 1 in the liver modulates high-fat diet-induced obesity and hepatic steatosis in mice. Luo X; Li Z; Chen L; Zhang X; Zhu X; Wang Z; Chen Y Metabolism; 2023 Jun; 143():155537. PubMed ID: 36933792 [TBL] [Abstract][Full Text] [Related]
16. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease. Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736 [TBL] [Abstract][Full Text] [Related]